AbCellera Biologics Inc. · NASDAQ:ABCL
Booth Andrew bought 8,600 AbCellera Biologics Inc. shares (Form 4)
Traded Nov 13, 2026 · Filed Nov 13, 2026
On Nov 13, 2026, Booth Andrew (Chief Financial Officer) bought 8,600 AbCellera Biologics Inc. shares at US$11.33 for US$97,438, leaving 491,400 shares. Filed Nov 13, 2026 (Form 4).
- Bought
- 8,600 shares
- Price
- US$11.33
- Value
- US$97,438
- Holding after
- 491,400 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Common Shares | Buy | 8,600 | US$11.33 | 491,400 | Direct |
Source
Download original · View original at SEC
Related
- AbCellera Biologics Inc.
- Booth Andrew
- AbCellera Biologics Inc. shareholders
- Form 4 · Booth Andrew · Nov 16, 2026
- Form 4 · Booth Andrew · Aug 14, 2026
- Form 4 · Booth Andrew · Jun 3, 2026
- Form 4 · Thermopylae Holdings Ltd. · Nov 13, 2026
- Schedule 13G/A · Carl L.G. Hansen · Nov 13, 2026
- Form 4 · Thermopylae Holdings Ltd. · Nov 12, 2026
- Form 4 · Hayden Michael R · Aug 24, 2026
- Form 4 · Montalbano John S. · Aug 18, 2026